Oral Insulin Substitutes

Abstract

Get full access to this article

View all access options for this article.

References

Baird

J. D.

Duncan

L. J. P.

(1957). The interpretation of the intravenous glucose tolerance test. Clin. Sci., 16, 147.

Bertram

Bendfeldt

Otto

(1955). Uber ein Wirksames Perorales Antidiabeticum (BZ55). Dtsch. med. Wschr., 80, 1,455.

Colwell

A. R.

(1956). Editorial: Oral antidiabetic sulphonamides. Diabetes, 5, 62.

Duncan

L. J. P.

Baird

J. D.

Dunlop

D. M.

(1956). A clinical trial of BZ55. Brit. med. J., 2, 433.

Fajans

S. S.

Louis

L. H.

Seltzer

H. S.

Gittler

R. D.

Hennes

A. R.

Wajchen-Berg

B. L.

Ackerman

I. P.

Conn

J. W.

(1956). Metabolic effects of arylsulfonurea compounds in normal man and diabetic subjects. Metabolism, 5, 820.

Franke

Fuchs

(1955). Ein neues Antidiabetisches Princip. Dtsch. med. Wschr., 80, 1,449.

Fulmer

H. S.

Dube

A. H.

Lloyd

C. W.

(1956). Clinical experience with orinase. Metabolism, 5, 946.

Goetz

F. C.

Gilbertsen

A. S.

Josephson

(1956). Acute effects of orinase on peripheral glucose utilization. Metabolism, 5, 788.

Hugh-Jones

(1955). Diabetes in Jamaica. Lancet, 2, 891.

10.

Janbon

Lazerges

Metropoli-Tanski

J. H.

(1942). Etude du metabolisme du sulfaisopropylthiadiazol chez le sujet et en cours de traitement comportement de la glycémie. Montpellier. Med., 21, 489.

11.

Levine

Duncan

G. C.

(1956). Editorial statement: Symposium on clinical and experimental effects of sulfonylureas in diabetes mellitus. Metabolism, 5, 721.

12.

Lewis

J. J.

(1949). Diabetes and the insulin-administration problem. Physiol. Rev., 29, 75.

13.

Long

C. N. H.

(1952). Endocrine control of the blood sugar. Lancet, 1, 325.

14.

Miller

Craig

J. w.

(1956). The use of tolbutamide (orinase) in the management of various types of diabetes mellitus and studies of possible mechanisms of its action. Metabolism, 5, 868.

15.

Moorehouse

J. A.

Kark

R. M.

(1956). Physiologic actions of orinase and their relationship to the types of diabetes in man. Metabolism, 5, 847.

16.

Phemister

J. C.

(1957). Thrombocytopaenia and leucopaenia following carbutamide. Brit. med. J., 1, 199.

17.

Stich

Marx

Erhart

(1956). Untersuchungen über die Wirkung von D860 auf Blut und Knockenmark. Dtsch. med. Wschr., 81, 844.

18.

Tunbridge

R. E.

(1957). The place of BZ55 (carbutamide) and allied compounds in the treatment of diabetes mellitus. Practitioner, 178, 109.

19.

Williams

R. H.

(1955). Textbook of endocrinology. 2nd Edition, Philadelphia. W. B. Saunders Co. p. 420.

20.

Wrenshall

G. A.

Best

C. H.

(1956). Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulphonylureas in the treatment of diabetes in man: A comparison. Canad. med. Ass. J., 74, 968.